The Pennant Group/$PNTG
1D1W1MYTD1Y5YMAX
Capital at risk
About The Pennant Group
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
- Ticker
- $PNTG
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 9,700
- Headquarters
- Eagle, United States
- Website
- pennantgroup.com
PNTG Metrics
BasicAdvanced
$1.4B
43.96
$0.91
1.29
-
Price and volume
Market cap
$1.4B
Beta
1.29
52-week high
$42.74
52-week low
$22.26
Average daily volume
303K
Financial strength
Current ratio
1.205
Quick ratio
0.974
Long term debt to equity
1.131
Total debt to equity
1.225
Interest coverage (TTM)
6.03%
Profitability
EBITDA (TTM)
74.57
Gross margin (TTM)
19.59%
Net profit margin (TTM)
2.93%
Operating margin (TTM)
5.85%
Effective tax rate (TTM)
26.89%
Revenue per employee (TTM)
$110,000
Management effectiveness
Return on assets (TTM)
4.50%
Return on equity (TTM)
10.42%
Valuation
Price to earnings (TTM)
43.965
Price to revenue (TTM)
1.261
Price to book
3.91
Price to tangible book (TTM)
-18.47
Price to free cash flow (TTM)
53.287
Free cash flow yield (TTM)
1.88%
Free cash flow per share (TTM)
0.751
Growth
Revenue change (TTM)
37.90%
Earnings per share change (TTM)
17.96%
3-year revenue growth (CAGR)
29.97%
3-year earnings per share growth (CAGR)
29.83%
What the Analysts think about PNTG
Analyst ratings (Buy, Hold, Sell) for The Pennant Group stock.
Analyst projections of the future price of The Pennant Group stock.
Bulls say / Bears say
Pennant delivered strong second-quarter momentum, with revenue up 35.8% and adjusted EBITDA up 48.2% year on year. Management raised its 2026 revenue, adjusted EBITDA and adjusted EPS guidance after saying results were on track to exceed the original outlook. (GlobeNewswire)
The mature business is still growing while Pennant integrates its Southeast acquisitions: same-store home health admissions rose 9.7%, same-store Medicare admissions 13.6% and same-store hospice average daily census 10.8%. Senior living also showed improving demand, with same-store occupancy up 150 basis points year on year. (Hospice News, GlobeNewswire)
The acquired Southeast portfolio offers a sizeable margin-upside opportunity. Pennant says the assets are currently running slightly above their 9.5% to 11.5% 2026 margin range and could approach its 18% target as optimisation continues through 2027 and 2028. (Home Health Care News, Hospice News)
Pennant is entering the fifth and largest wave of its Southeast integration, and management warned that results could become lumpy through year end. The acquired portfolio is uneven, so the promised margin improvement is unlikely to arrive in a smooth or immediate way. (Home Health Care News, Hospice News)
Reimbursement remains a material earnings risk: Pennant reported that its mature operations faced a 1.3% home health reimbursement cut in the first quarter. Its latest results also continue to flag lower prices and reimbursement rates as risks to profitability. (GlobeNewswire, GlobeNewswire)
Hospice is under heightened fraud and abuse scrutiny, which is already adding administrative costs and could bring tighter regulation. That creates compliance risk for Pennant even if enforcement is aimed primarily at bad actors elsewhere in the sector. (StockAnalysis, GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.
PNTG Financial Performance
Revenues and expenses
PNTG Earnings Performance
Company profitability
Upcoming events
No upcoming events
PNTG News
AllArticlesVideos
Funds containing PNTG
AllEURGBPUSD
Fund name | Fund size | $PNTG weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.12% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.07% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.07% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.05% |
Xtrackers S&P 500 Swap£XSPX | £3.1B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.